Genevieve Laforet

Genevieve Laforet

Company: Aspa Therapeutics

Job title: Vice President - Clinical Development


Complement Activation & Thrombotic Microangiopathy Associated with AAV Gene Therapy 1:30 pm

Overview of the complement system and complementopathies Thrombotic microangiopathy (TMA) associated with AAV gene therapy: atypical hemolytic-uremic syndrome (aHUS) Case characteristics of AAV-associated TMA/aHUS Surveillance, diagnosis and managementRead more

day: Day Two

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.